Trending...
- Sober.Buzz the Sober Token : Ticker $BUZZ
- Global Families Turn to Young Travelers Concierge Amid Rising Safety Concerns in the U.S
- UIFCA Revolutionizes Financial Education with Elite Team of Investment Experts
SYDNEY - AussieJournal -- Today, the Australian Chiropractors Association (ACA) launched national Spinal Health Week (20 - 26 May 2024) with the release of new independent findings on the prevalence of back pain due to spine related musculoskeletal disorders (MSDs).
The Impact of Back Pain & Musculoskeletal Injuries in Australia, an independent national consumer survey conducted by Pureprofile, revealed that of the 1006 respondents, over 98% (98.5% of women and 98.0% of men) experienced a back related MSD in the past 12 months.
Of all respondents, 30% reported low back pain as the most chronic (long-lasting) MSD condition. 28% reported experiencing moderate low back pain which interfered significantly with daily life, while 35% of low back pain sufferers classified the pain as moderate and 8% said it was severe.
According to the ABS (Oct 2023), in June 2023, Australia had 10.4 million households. With over 80% of survey respondents reporting that their household had occupants who experienced back pain, this figure suggests that 8.35 million Australian households are likely to have residents who suffer back pain.
Dr David Cahill, President of the ACA said, "Of concern is the survey showed that a large number (50%) of MSD sufferers had failed to seek a medical diagnosis, while 64% of low back pain sufferers also reported not seeking a diagnosis suggesting that official data may not reflect the true prevalence of MSDs and back pain in Australia."
More on Aussie Journal
The first World Health Organisation (WHO) guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings (Dec 2023), developed from in depth research by a world-wide range of neuro-musculoskeletal health practitioners including chiropractors; recommends optimising the clinical management of people with chronic primary low back pain or non-specific low back pain, as a priority for WHO Member States.
However, 81% of low back pain sufferers opted to treat symptoms with over the counter or prescription medications rather than seek treatment, with 13% using pain relief medications daily, 12% using it frequently (3+ days per week) and 12% taking pain relief medications often (one to two times per week).
Significantly, women reported the greatest use of pain relief medication for low back pain (82.2%) with 14% taking it daily, 13% frequently and 13.5% said they used medication to relieve back pain often.
Although older Australians are considered high risk for MSDs and low back pain, others most at risk include those who do strenuous physical work including lifting, repetitive actions or standing for extended periods.
Inactive Australians who don't exercise and spend long hours sitting at work or at home are also at risk of developing musculoskeletal problems that can impact their quality of life and overall health and wellbeing.
According to the survey, 6,368 MSDs were reported. The dominant three MSDs impacting the lives of Australian's were low back pain (80.6%), neck pain (67.9%) and mid back pain (66.3%). 75% of respondents aged 18-60 within the peak working age reported back pain with 17.9% of MSDs requiring workers compensation.
More on Aussie Journal
For those who experience persistent symptoms beyond three months, known as chronic primary low back pain, the pain is often not caused by any particular condition.
Dr Cahill said, "While the annual cost of MSDs to the Australian economy exceeds $55.1 billion in direct health costs, lost productivity, reduced quality of life and increased disability, the personal cost to sufferers of persistent low back pain can be life-limiting having a negative impact on their mental health and overall wellbeing while placing a substantial financial burden on families, communities, and our healthcare system."
The survey results, together with the World Health Organisation's (WHO) analysis that MSDs account for the greatest proportion of persistent pain conditions and are the second largest contributor to disability worldwide with low back pain the single leading cause of disability globally; form a compelling case for a proactive, strategic response to how Australians approach back pain.
Seeking appropriate healthcare options that can limit the use of medications by treating the cause of the condition with recommended exercises can help prevent reoccurrence.
For more visit: www.spinalhealthweek.org.au
Media Centre: https://bit.ly/SHW-24
The Impact of Back Pain & Musculoskeletal Injuries in Australia, an independent national consumer survey conducted by Pureprofile, revealed that of the 1006 respondents, over 98% (98.5% of women and 98.0% of men) experienced a back related MSD in the past 12 months.
Of all respondents, 30% reported low back pain as the most chronic (long-lasting) MSD condition. 28% reported experiencing moderate low back pain which interfered significantly with daily life, while 35% of low back pain sufferers classified the pain as moderate and 8% said it was severe.
According to the ABS (Oct 2023), in June 2023, Australia had 10.4 million households. With over 80% of survey respondents reporting that their household had occupants who experienced back pain, this figure suggests that 8.35 million Australian households are likely to have residents who suffer back pain.
Dr David Cahill, President of the ACA said, "Of concern is the survey showed that a large number (50%) of MSD sufferers had failed to seek a medical diagnosis, while 64% of low back pain sufferers also reported not seeking a diagnosis suggesting that official data may not reflect the true prevalence of MSDs and back pain in Australia."
More on Aussie Journal
- Cosca and Hogan & Associates Join Forces to Strengthen Accounting Support for Regional Queensland
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
The first World Health Organisation (WHO) guideline for non-surgical management of chronic primary low back pain in adults in primary and community care settings (Dec 2023), developed from in depth research by a world-wide range of neuro-musculoskeletal health practitioners including chiropractors; recommends optimising the clinical management of people with chronic primary low back pain or non-specific low back pain, as a priority for WHO Member States.
However, 81% of low back pain sufferers opted to treat symptoms with over the counter or prescription medications rather than seek treatment, with 13% using pain relief medications daily, 12% using it frequently (3+ days per week) and 12% taking pain relief medications often (one to two times per week).
Significantly, women reported the greatest use of pain relief medication for low back pain (82.2%) with 14% taking it daily, 13% frequently and 13.5% said they used medication to relieve back pain often.
Although older Australians are considered high risk for MSDs and low back pain, others most at risk include those who do strenuous physical work including lifting, repetitive actions or standing for extended periods.
Inactive Australians who don't exercise and spend long hours sitting at work or at home are also at risk of developing musculoskeletal problems that can impact their quality of life and overall health and wellbeing.
According to the survey, 6,368 MSDs were reported. The dominant three MSDs impacting the lives of Australian's were low back pain (80.6%), neck pain (67.9%) and mid back pain (66.3%). 75% of respondents aged 18-60 within the peak working age reported back pain with 17.9% of MSDs requiring workers compensation.
More on Aussie Journal
- Adster Techologies awarded US Patent for breakthrough innovation in reducing latency in Ad Serving
- This Mother's Day, Give the Gift of Comfort Climate Green Offers Big Discounts on Air Conditioning
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
For those who experience persistent symptoms beyond three months, known as chronic primary low back pain, the pain is often not caused by any particular condition.
Dr Cahill said, "While the annual cost of MSDs to the Australian economy exceeds $55.1 billion in direct health costs, lost productivity, reduced quality of life and increased disability, the personal cost to sufferers of persistent low back pain can be life-limiting having a negative impact on their mental health and overall wellbeing while placing a substantial financial burden on families, communities, and our healthcare system."
The survey results, together with the World Health Organisation's (WHO) analysis that MSDs account for the greatest proportion of persistent pain conditions and are the second largest contributor to disability worldwide with low back pain the single leading cause of disability globally; form a compelling case for a proactive, strategic response to how Australians approach back pain.
Seeking appropriate healthcare options that can limit the use of medications by treating the cause of the condition with recommended exercises can help prevent reoccurrence.
For more visit: www.spinalhealthweek.org.au
Media Centre: https://bit.ly/SHW-24
Source: Australian Chiropractors Association
Filed Under: Health
0 Comments
Latest on Aussie Journal
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Climate Green: Melbourne's Trusted VEU Accredited Provider Making Electrification Easy with Expert
- Surf Coast Region Emerges as Victoria's Entrepreneurial Powerhouse
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- Psychiatry's Legacy of Racism and Coercion Highlighted in Restraint Deaths
- New Book 'Cybersecurity Leadership' Guides SME Leaders to Make Smart, Strategic Security Decisions
- "Stop scrolling and start watching" - Beloved film recommendation site Criticker gets a major makeover
- Green Energy Solar Expands with New Offices in Port St. Lucie, West Palm Beach, and Orlando
- Events by Dubsdread Expands Services to The Venue at Lake Lily
- London Gala Emphasizes Trade, FDI and Ongoing Cooperation
- Freedom Presents Art-full-life. Where Homewares Become Masterpieces